Using Economic evaluation in policy decision-making in Asian countries: Mission impossible or mission probable?

Value in Health

Volumn 12, Issue SUPPL. 3, 2009, Pages

  Yothasamut, Jomkwan ^a   Tantivess, Sripen ^a   Teerawattananon, Yot ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Asia; Economic evaluation; Health resource allocation; Health technology assessment; Latin America; Policy decision making

Indexed keywords

ASIAN; DECISION MAKING; ECONOMIC EVALUATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW;

EID: 72149130932     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00623.x     Document Type: Review

References (31)

1. Singer ME. Cost-effectiveness analysis: developing nations left behind. Pharmacoeconomics 2008 26 : 359 361.
2. Tarn YH, Hu S, Kamae I, et al. Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health 2008 11 (Suppl. 1 S137 55.
3. Hoffmann C. The influence of economic evaluation studies on decision making: a European survey. Health Policy 2000 52 : 179 192.
4. Harris A, Buxton M, O'Brien B, et al. Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries. Exp Rev Pharmacoeconom Res 2001 1 : 7 12.
5. Drummond M, Jonsson B, Rutten F. The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy 1997 40 : 199 215.
6. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004 329 : 224 227.
7. Anell A, Svarvar P. Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees. Pharmacoeconomics 2000 17 : 175 185.
8. Mobley LR, Hoerger TJ, Wittenborn JS, et al. Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate. Med Decis Making 2006 26 : 194 206.
9. Lee KS, Brouwer WB, Lee SI, Koo HW. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics 2005 23 : 709 721.
10. Teerawattananon Y, Russell S, Mugford M. A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers? Pharmacoeconomics 2007 25 : 467 479.
11. Iglesias CP, Drummond MF, Rovira J. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care 2005 21 : 1 14.
12. Drummond M. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal. Soc Sci Med 1994 38 : 1593 1600. (Pubitemid 24132935)
13. Teerawattananon Y, Russell S. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand. Value Health 2008 11 (Suppl. 1 S52 60.
14. Teerawattananon Y, Tangcharoensathien V. Designing a reproductive health services package in the universal health insurance scheme in Thailand: match and mismatch of need, demand and supply. Health Policy Plan 2004 19 (Suppl. 1 i31 9.
15. International Society for Pharmacoeconomics and Outcomes Research. Pharmacoeconomics guidelines around the world. Country-specific pharmacoeconomic guidelines. 2009. Available from: http://www.ispor.org/PEguidelines/index.asp [Accessed June 5, 2009 N, Drummond M, Fukuhara S, et al. Why has the use of health economic evaluation in Japan lagged behind that in other developed countries? Pharmacoeconomics 2002 20 (Suppl. 2 S1 7.
16. Yang BM, Bae EY, Kim J. Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance. Health Aff (Millwood) 2008 27 : 179 187.
17. Neumann P. Using Cost-Effectiveness Analysis to Improve Health Care: Opportunities and Barriers. Oxford : Oxford University Press, 2005.
18. Ubel P. Pricing Life: Why It's Time for Health Care Rationing. Cambridge, MA : The MIT Press, 2000.
19. Teerawattananon Y, Russell S. The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand. BMC Health Serv Res 2008 8 : 197.
20. Ferner RE, McDowell SE. How NICE may be outflanked. BMJ 2006 332 : 1268 1271.
21. Tantivess S, Walt G. Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand. Cost Eff Resour Alloc 2006 4 : 21.
22. Tangcharoensathien V, Kamolratanakul P. Making sensible rationing: the use of economic evidence and the need for methodological standards. J Med Assoc Thai 2008 91 (Suppl. 2 S4 7.
23. Wonder MJ, Neville AM, Parsons R. Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003. Value Health 2006 9 : 205 212.
24. Cairns J. Providing guidance to the NHS: the Scottish Medicines Consortium and the National Institute for Clinical Excellence compared. Health Policy 2006 76 : 134 143.
25. Kapol N, Maitreemit P, Chalongsuk R, et al. Making health technology assessment information available for decision making: the development of a Thai database. J Med Assoc Thai 2008 91 (Suppl. 2 S8 10.
26. de Pouvourville G, Ulmann P, Nixon J, et al. The diffusion of health economics knowledge in Europe: the EURONHEED (European Network of Health Economics Evaluation Database) project. Pharmacoeconomics 2005 23 : 113 120.
27. Goodman C. Introduction to health care technology assessment. National Library of Medicine, 1998. Available from: http://www.nlm.nih.gov/nichsr/hta101/ ta101-c1.html [Accessed September 10, 2009].
28. Sassi F. Setting priorities for the evaluation of health interventions: when theory does not meet practice. Health Policy 2003 63 : 141 154.
29. Tantivess S, Teerawattananon Y, Mills A. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Pharmacoeconomics 2009 in press.
30. Robinson R. Limits to rationality: economics, economists and priority setting. Health Policy 1999 49 : 13 26.
31. Singleton J, McLaren S. Ethical Foundations of Health Care: Responsibilities in Decision Making. London : Mosby, 1995.